ERBB3: A Potential Serum Biomarker for Early Detection and Therapeutic Target for Devil Facial Tumour 1 (DFT1)

PLoS ONE- United States

doi 10.1371/journal.pone.0177919

Full Text

Abstract

Available in

Categories

Multidisciplinary

Date

June 7, 2017

Authors

Robyn L. Taylor

Stephen B. Pyecroft

Sukhwinder Singh Sohal

Elizabeth T. Snow

Publisher

Public Library of Science (PLoS)

Related search

MiR-30a: A Novel Biomarker and Potential Therapeutic Target for Cancer

Journal of Oncology

English

CD83 Is a New Potential Biomarker and Therapeutic Target for Hodgkin Lymphoma

English

ROR2 Is a Novel Prognostic Biomarker and a Potential Therapeutic Target in Leiomyosarcoma and Gastrointestinal Stromal Tumour

Journal of Pathology

Forensic Medicine

English

Transgelin in Bladder Cancer: A Potential Biomarker and Therapeutic Target

Molecular Biology

English

C-Met as a Potential Therapeutic Target and Biomarker in Cancer

Therapeutic Advances in Medical Oncology

English

Systematic Approach Identifies RHOA as a Potential Biomarker Therapeutic Target for Asian Gastric Cancer

English

Saturated and Mono-Unsaturated Lysophosphatidylcholine Metabolism in Tumour Cells: A Potential Therapeutic Target for Preventing Metastases

Lipids in Health and Disease

Clinical Biochemistry

English

Kim-1/Tim-1: From Biomarker to Therapeutic Target?

Nephrology Dialysis Transplantation

Transplantation

English

Identification of Kininogen-1 as a Serum Biomarker for the Early Detection of Advanced Colorectal Adenoma and Colorectal Cancer

Multidisciplinary

English